These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 841610)
1. [In-vivo-examinations of the relative radiosensitivity of hypoxic tumor cells (author's transl)]. Bosiljanoff P; Porschen W; Piepenbring W; Mühlensiepen H; Feinendegen LE Strahlentherapie; 1977 Mar; 153(3):178-89. PubMed ID: 841610 [TBL] [Abstract][Full Text] [Related]
2. Cell loss from viable and necrotic tumor regions after local gamma irradiation measured by 125I-UdR. Bornschein R; Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE Strahlenther Onkol; 1987 Feb; 163(2):114-22. PubMed ID: 3563871 [TBL] [Abstract][Full Text] [Related]
3. Repair of radiation damage in Lewis lung carcinoma cells following in situ treatment with fast neutrons and gamma-rays. Shipley WU; Stanley JA; Courtenay VD; Field SB Cancer Res; 1975 Apr; 35(4):932-8. PubMed ID: 1120301 [TBL] [Abstract][Full Text] [Related]
4. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy. Griffin RJ; Williams BW; Park HJ; Song CW Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1516-22. PubMed ID: 15817358 [TBL] [Abstract][Full Text] [Related]
5. [In vivo measurement of different radiosensitivity of tumor cells during the cell cycle; cell labeling using 125 I-deoxyuridine]. Pittner W; Porschen W; Feinendegen LE Strahlentherapie; 1973 Feb; 145(2):161-8. PubMed ID: 4694653 [No Abstract] [Full Text] [Related]
6. Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams. Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Sakurai Y; Nagata K; Suzuki M; Kashino G; Kinashi Y; Tanaka H; Maruhashi A; Ono K Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):221-8. PubMed ID: 18086390 [TBL] [Abstract][Full Text] [Related]
7. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo. Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Ono K Acta Oncol; 2008; 47(6):1087-93. PubMed ID: 18607878 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying reduced growth rate in C3HBA mammary adenocarcinomas recurring after single doses of x-rays or fast neutrons. Nelson JS; Carpenter RE; Durboraw D Cancer Res; 1976 Feb; 36(2 Pt 1):524-31. PubMed ID: 1260751 [TBL] [Abstract][Full Text] [Related]
9. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy. Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904 [TBL] [Abstract][Full Text] [Related]
10. An historical survey of radiobiology and radiotherapy with fast neutrons. Field SB Curr Top Radiat Res Q; 1976 Jan; 11(1):1-86. PubMed ID: 1106959 [TBL] [Abstract][Full Text] [Related]
11. [IV. Studies on cell biological experiments to the relative biological effectiveness (RBE) of fast neutrons in different phantom depths (author's transl)]. Magdon E Arch Geschwulstforsch; 1975; 45(8):746-52. PubMed ID: 1230122 [TBL] [Abstract][Full Text] [Related]
12. Relative biological effectiveness of 6 MeV neutrons with respect to cell inactivation and disturbances of the G1 phase. Zölzer F; Streffer C Radiat Res; 2008 Feb; 169(2):207-13. PubMed ID: 18220459 [TBL] [Abstract][Full Text] [Related]
13. [Biological in vivo dosimetry of 15 MeV neutrons in normal and tumor cells-cell marking with iodine-125-deoxyuridine]. Porschen W; Feinendegen LE Strahlentherapie; 1973 Jan; 145(1):27-38. PubMed ID: 4713024 [No Abstract] [Full Text] [Related]
14. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533 [TBL] [Abstract][Full Text] [Related]
15. Interpretation of cytogenetic damage induced in the germ line of male mice exposed for over 1 year to 239Pu alpha particles, fission neutrons, or 60Co gamma rays. Grahn D; Lee CH; Farrington BF Radiat Res; 1983 Sep; 95(3):566-83. PubMed ID: 6611862 [TBL] [Abstract][Full Text] [Related]
16. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Baumann M; Dubois W; Suit HD Radiat Res; 1990 Sep; 123(3):325-30. PubMed ID: 2145606 [TBL] [Abstract][Full Text] [Related]
17. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Jordan BF; Grégoire V; Demeure RJ; Sonveaux P; Feron O; O'Hara J; Vanhulle VP; Delzenne N; Gallez B Cancer Res; 2002 Jun; 62(12):3555-61. PubMed ID: 12068004 [TBL] [Abstract][Full Text] [Related]
18. Response of chronic hypoxic cells to low dose-rate irradiation. Pettersen EO; Bjørhovde I; Søvik A; Edin NF; Zachar V; Hole EO; Sandvik JA; Ebbesen P Int J Radiat Biol; 2007 May; 83(5):331-45. PubMed ID: 17457758 [TBL] [Abstract][Full Text] [Related]
19. Radiosensitivity of late recurrences following radiotherapy of murine fibrosarcomas. Ando K; Koike S; Shikita M; Hayata I; Otsu H; Satoh S Radiat Res; 1988 Feb; 113(2):334-45. PubMed ID: 3340737 [TBL] [Abstract][Full Text] [Related]
20. [Physical and biological parameters of interest for evaluating the possible use of pi-mesons, neutrons and charged particles in radiotherapy (author's transl)]. Jung H; Zimmer KG Rontgenblatter; 1974 Aug; 27(8):381-402. PubMed ID: 4214365 [No Abstract] [Full Text] [Related] [Next] [New Search]